PCA — Pcas SA Income Statement
0.000.00%
HealthcareSpeculativeSmall Cap
- €109.93m
- €181.98m
- €226.36m
Annual income statement for Pcas SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 207 | 201 | 194 | 187 | 226 |
Cost of Revenue | |||||
Gross Profit | 90.5 | 81.7 | 80.2 | 64.8 | 74 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 204 | 210 | 205 | 216 | 269 |
Operating Profit | 2.83 | -8.71 | -11 | -28.6 | -42.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.618 | -10.8 | -12.5 | -31.5 | -45.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.35 | -13.7 | -14.9 | -40.5 | -48.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -0.358 | -13.7 | -14.9 | -40.5 | -48.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.358 | -13.7 | -14.9 | -40.5 | -48.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.022 | -0.932 | -1.05 | -2.93 | -2.84 |
Dividends per Share |